Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAX576 in moderate persistent allergic asthma
NCT00598104Phase 2Withdrawn
- Sponsor
- Novartis
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of dectrekumab in allergic asthma, sponsored by Novartis. Planned start Jan 2008; status: withdrawn.
02
Drugs
dectrekumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00598104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598104.